所有图片(3)
About This Item
线性分子式:
(CH3)4C2O2BC3N2H3
CAS号:
分子量:
194.04
MDL编号:
UNSPSC代码:
12352103
PubChem化学物质编号:
NACRES:
NA.22
推荐产品
质量水平
方案
97%
表单
solid
mp
142-146 °C (lit.)
SMILES字符串
CC1(C)OB(OC1(C)C)c2cn[nH]c2
InChI
1S/C9H15BN2O2/c1-8(2)9(3,4)14-10(13-8)7-5-11-12-6-7/h5-6H,1-4H3,(H,11,12)
InChI key
TVOJIBGZFYMWDT-UHFFFAOYSA-N
应用
试剂用于
用于制备含优势骨架吡唑的许多非常重要的治疗酶和激酶的抑制剂的试剂,包括
- Suzuki-Miyaura 交叉耦合
- 钌催化不对称氢化
用于制备含优势骨架吡唑的许多非常重要的治疗酶和激酶的抑制剂的试剂,包括
- VEGF
- 极光
- Rho(岩石)
- Janus 激酶 2 (JAK)
- c-MET
- ALK
- S-亚硝基谷胱甘肽还原酶
- CDC7
- 乙酰辅酶A羧化酶
- 促存活 Bcl-2 蛋白
- 病毒 RNA 依赖性 RNA 聚合酶
- 长链脂肪酸延长酶 6
- PI3
- AKT
- Chk1
- 蛋白激酶 B
法律信息
Boron Molecular 制造
警示用语:
Warning
危险声明
危险分类
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 3
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases
Matthews, T. P.; et al.
Bioorganic & Medicinal Chemistry, 20, 4045-4049 (2010)
Robert M Garbaccio et al.
Bioorganic & medicinal chemistry letters, 17(22), 6280-6285 (2007-09-29)
From HTS lead 1, a novel benzoisoquinolinone class of ATP-competitive Chk1 inhibitors was devised and synthesized via a photochemical route. Using X-ray crystallography as a guide, potency was rapidly enhanced through the installation of a tethered basic amine designed to
Christoffer Bengtsson et al.
Bioorganic & medicinal chemistry, 19(10), 3039-3053 (2011-04-26)
Inhibition of acetyl-CoA carboxylases has the potential for modulating long chain fatty acid biosynthesis and mitochondrial fatty acid oxidation. Hybridization of weak inhibitors of ACC2 provided a novel, moderately potent but lipophilic series. Optimization led to compounds 33 and 37
Dirk A Heerding et al.
Journal of medicinal chemistry, 51(18), 5663-5679 (2008-09-20)
Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monotherapy
Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors
Chen, Y-T.; et al.
MedChemComm, 2, 73-75 (2011)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门